Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:1612-1615

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biemond, B. J.
Right arrow Articles by Cate, J. W. t.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biemond, B. J.
Right arrow Articles by Cate, J. W. t.

(Circulation. 1997;96:1612-1615.)
© 1997 American Heart Association, Inc.


Articles

Apolipoprotein(a) Attenuates Endogenous Fibrinolysis in the Rabbit Jugular Vein Thrombosis Model In Vivo

Bart J. Biemond, MD; Philip W. Friederich, MD; Marlys L. Koschinsky, PhD; Marcel Levi, MD; Waheed Sangrar, PhD; Jiazhi Xia, PhD; Harry R. Büller, MD; ; Jan W. ten Cate, MD

From the Center for Hemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Academic Medical Center, University of Amsterdam, Netherlands (B.J.B., P.W.F., M.L., H.R.B., J.W. ten C.), and the Department of Biochemistry, Queen's University, Kingston, Ontario, Canada (M.L.K., W.S., J.X.).

Correspondence to Marcel Levi, MD, Center for Hemostasis, Thrombosis, Atherosclerosis, and Inflammation Research, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands.

Background In many case-control as well as epidemiological studies, increased lipoprotein(a) [Lp(a)] levels are considered to constitute an independent risk factor for premature coronary artery and cerebrovascular disease. Lp(a) resembles an LDL particle with an additional linked protein [apolipoprotein(a), apo(a)], whose molecular structure has been demonstrated to be homologous to the fibrinolytic proenzyme plasminogen. Because of the high similarity between plasminogen and apo(a), apo(a) may potentially interfere in the fibrinolytic system by competing with plasminogen for fibrin binding sites. In vitro studies have demonstrated that Lp(a) indeed competes with plasminogen binding to fibrin and inhibits tissue plasminogen activator (TPA)-mediated activation of plasminogen. No direct in vivo studies to test this hypothesis have been performed.

Methods and Results To test this hypothesis, we studied the effect of a recombinant form of apo(a) on endogenous and TPA-mediated thrombolysis in an in vivo model of experimental venous thrombosis. Thrombi containing either 16 µg r-apo(a), 8 µg r-apo(a), or vehicle (HEPES-buffered saline, control) were formed in the jugular veins of a rabbit and showed significantly reduced endogenous thrombolysis after 60 minutes in a dose-dependent fashion, ID 2.7±0.9% and 4.6±1.8%, respectively, versus 7.4±1.6% of that of the control. High concentrations of incorporated apo(a) significantly reduced TPA-induced thrombolysis (12.2±2.5% versus 22.2±2.6% in the control thrombi), but no effect of lower concentrations of incorporated r-apo(a) was demonstrated on the exogenous TPA-induced thrombolysis.

Conclusions The present study demonstrates the attenuation of endogenous fibrinolysis by apo(a) in an in vivo model of experimental venous thrombosis, lending support to the proposed mechanism of impaired fibrinolysis by which Lp(a) may contribute to atherothrombotic disorders.


Key Words: plasminogen activators • fibrinolysis • thrombolysis • plasminogen • apolipoproteins




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. Levi, T. T Keller, E. van Gorp, and H. ten Cate
Infection and inflammation and the coagulation system
Cardiovasc Res, October 15, 2003; 60(1): 26 - 39.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Hancock, M. B. Boffa, S. M. Marcovina, M. E. Nesheim, and M. L. Koschinsky
Inhibition of Plasminogen Activation by Lipoprotein(a): CRITICAL DOMAINS IN APOLIPOPROTEIN(a) AND MECHANISM OF INHIBITION ON FIBRIN AND DEGRADED FIBRIN SURFACES
J. Biol. Chem., June 20, 2003; 278(26): 23260 - 23269.
[Abstract] [Full Text] [PDF]


Home page
Protein Eng Des SelHome page
M. N. Rahman, V. Petrounevitch, Z. Jia, and M. L. Koschinsky
Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen binding
Protein Eng. Des. Sel., June 1, 2001; 14(6): 427 - 438.
[Abstract] [Full Text] [PDF]